9 -tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood.
Introduction
Cannabis remains the most widely used illicit substance worldwide. The regular use of cannabis often begins during adolescence which is of particular concern because this period is crucial to generate efficient neuronal pathways by constant neuroplastic shaping, synaptic reorganization and neurochemical changes (Sturman and Moghaddam, 2011) . Pharmacological and/or environmental factors affecting the endocannabinoid system during the adolescent period can lead to altered brain maturation considering the important role played by this https://doi.org/10. 1016/j.neuropharm.2018.11.016 Received 17 April 2018; Received in revised form 17 October 2018; Accepted 10 November 2018 system in the neurodevelopmental changes that occur during this time (Fernández-Ruiz et al., 2000; Harkany et al., 2007) . As a consequence, preclinical and epidemiological data suggest that adolescent cannabinoid exposure may increase the risk for the appearance of psychiatric diseases in adult life (Malone et al., 2010; Higuera-Matas et al., 2015) , including emotional dysregulation. Recent studies relate cannabis use in adolescence with amygdala hypersensitivity to signals of threat (Spechler et al., 2015) , and with an increased likelihood of having posttraumatic stress disorder symptoms in adulthood (Lee et al., 2018) . Other disturbances associated with adolescent cannabis use may include psychotic-like symptoms, cognitive deficits, and increased addiction vulnerability (Silins et al., 2014; Renard et al., 2016) .
Most psychiatric disorders involve multiple ethiopathological factors that can interact across the lifespan and trigger disease onset (Caspi and Moffitt, 2006) . The interaction between cannabis consumption and genetic or environmental factors during adolescence may have a crucial influence in the detrimental effects of this drug later in life (Rubino and Parolaro, 2016) . Adult mice with genetic mutations in some genes involved in schizophrenia (O'Tuathaigh et al., 2012; Long et al., 2013; Ballinger et al., 2015) or exposed to stressful events early in life (Llorente-Berzal et al., 2011; Zamberletti et al., 2012; Klug and van den Buuse, 2012) showed altered behavioural responses due to Δ 9 -tetrahydrocannabinol (THC) adolescent treatment. This interaction of cannabis exposure and genetic/environmental events produces protective or negative effects depending on the genetic profile, sex, and stress level (Rubino and Parolaro, 2016) .
The most consistent consequences of adolescent cannabinoid exposure are related to long-term impairments in cognitive function. Thus, numerous studies have shown working memory deficits in animals exposed to different cannabinoid agonists during adolescence (Renard et al., 2016) . The consequences in emotional memory have been less studied, although adolescent THC administration did not produce lasting effects in this behaviour (Ballinger et al., 2015; Rubino et al, 2009a Rubino et al, , 2009b . However, whether adolescent cannabinoid exposure alone or in combination with environmental factors such as stress affects the extinction of fear memory in adult life remains to be elucidated. Cannabis consumption and stressful events are often associated (Ketcherside and Filbey, 2015) . The effects in adulthood of cannabis consumption during adolescence may be exacerbated by stress exposure in this period of life. Moreover, stress and fear responses share common neural circuits, and the neuronal structures involved in fear acquisition and extinction are also highly sensitive to stress effects (Stockhorst and Antov, 2016) .
Here, we reveal that concomitant THC and stress adolescent exposure induces long-term impairment in fear extinction. This effect is associated with reduced neuronal activity and structural plasticity changes in key limbic brain regions. These findings suggest that THC chronic consumption under stress conditions during adolescence may increase the risk for the appearance of anxiety disorders related to trauma exposure.
Materials and methods

Animals
Adolescent female and male, and adult male C57BL6/J mice (Charles River, France) were used in these experiments. Animals were housed 3-5 per cage in a room with controlled temperature (21 ± 1°C), and humidity (55 ± 10%) and with a 12 h light/12 h dark cycle. All behavioural studies were conducted during the light period. Food and water were available ad libitum. Animal procedures were performed in accordance with the guidelines of the European Communities Council Directive 2010/63/EU and approved by the local ethical committee (CEEA-IMAS-UPF), and the statement of compliance with standards for use of laboratory animals by foreign institutions nr. 5388-01 approved by the National Institutes of Health. All behavioural data were obtained by experimental observers blinded to the experimental conditions.
Drugs
THC stored at 100 mg/ml in ethanol (THC-Pharm-GmbH, Germany) was diluted in 5% Tween-80 and physiological saline solution to achieve doses of 3, 6 and 12 mg/kg (5 ml/kg of body weight).
Experimental designs
Adolescent THC treatment
The long-term effects of THC administration in anxiety-like responses, locomotor activity, and fear conditioning expression and extinction were evaluated in adolescent male and female mice. Adolescence, which is a vulnerable period for the onset of neuropsychiatric disorders, covers the complete time span from childhood (shortly before puberty) to adulthood, including the pubertal period (Schneider, 2013) . The timing of human adolescence is difficult to define (Schneider, 2008) , and therefore the exact timing of this period in laboratory rodents represents a challenge in animal research (Schneider, 2013) . Starting at PND 35, mice were subcutaneously administered with increasing doses of THC (PND 35-39: 3 mg/kg, PND 40-44: 6 mg/kg, and PND 45-49: 12 mg/kg) or vehicle during 15 days in order to counter the development of drug tolerance (Renard et al., 2017) . Similar protocols using escalating doses of THC during adolescence have been previously used in numerous studies (Rubino et al., 2008; Llorente-Berzal et al., 2013; Cadoni et al., 2015) . Moreover, comparable time frames for adolescent cannabinoid treatment in both male and female rodents have been previously reported (Biscaia et al., 2003; Rubino et al., 2008; Realini et al., 2011; Bortolato et al., 2014; Zamberletti et al., 2014) . Male and female mice could be at different stages of the development at the onset and during the treatment schedule. However, the objective of our study was to evaluate in adult mice the possible effects of THC treatment during the adolescent period, a crucial life stage for the neuronal development. From PND 50 to 69, animals remained undisturbed. At PND 70, behavioural evaluation was carried out in the order described in Fig. 1A for male and in Fig. S1 for female mice. The interval of time between adolescent THC or vehicle treatment and adult behavioural experiments is similar to those used in previous reports (Quinn et al., 2008; Llorente-Berzal et al., 2013) . On the other hand, long-term stress of injection effects during adolescence (Keeley et al., 2015; Simone et al, 2018a Simone et al, , 2018b ) have been previously reported, which may reflect a greater vulnerability of adolescent animals to repeated physical stress exposure. However, control groups were injected with vehicle in our experimental protocols suggesting that the effects observed in mice treated with THC were due to this drug.
Concomitant THC and stress adolescent exposure
To assess the interaction between THC and mild stress, adolescent male mice treated with THC or vehicle, as previously described, were exposed to different stressors: forced swimming, tail suspension and restraint. Similar stressors, applied singly or in combination, either acutely or chronically, have been used in previous studies to investigate the role of stress in fear processing (Maren and Holmes, 2016) . At the end of each 5-days vehicle or THC exposure, one stressor was applied as shown in Fig. 2A . Moreover, two additional stressors were applied at PND 60 (forced swimming) and 65 (tail suspension) ( Fig. 2A) . Behavioural evaluation was carried out at PND 70 in the order shown in Fig. 2A .
Concomitant THC and stress adult exposure
To evaluate whether the long-term effects of simultaneous THC and stress exposure were age dependent, a similar experimental design was performed in adult male mice (Fig. S2A ). Starting at PND 56, mice were subcutaneously administered with increasing doses of THC (PND 56-60: 3 mg/kg, PND 61-65: 6 mg/kg, and PND 66-70: 12 mg/kg) or vehicle during 15 days. At the end of each 5-days THC exposure one stressor was applied as previously described (Fig 2A and Fig. S2A ). Two additional stressors were applied at PND 80 (forced swimming) and 85 (tail suspension). Behavioural evaluation was carried out at PND 90 in the order described in Fig. S2A . Mice were placed in a clear Plexiglas cylinder containing water (20 ± 1°C) for 6 min. The depth of the container and the volume of water were enough to prevent the animal from touching the bottom, thus forcing mice to swim. 
Tail suspension
Animals were suspended by a 15 cm thin string hanged from a metal rod and stuck with adhesive tape 1 cm from the tip of the tail. The front paws were sufficiently distant to the ground to avoid mice touching it. Tail suspension was performed during 6 min.
Restraint
Stress was induced by immobilizing the animal with a restrainer apparatus. Mice were placed individually inside a 50 ml conical tube with 0.5 cm air holes for breathing without access to food or water for 30 min. 
Behavioural experiments 2.5.1. Locomotor activity
Changes in horizontal activity were assessed by using locomotor activity boxes (9 × 20 × 11 cm, Imetronic, France). Mice were placed in locomotor cages with low luminosity. Activity was measured as the total number of horizontal photocell counts during 15 min.
Elevated plus maze
Elevated plus maze was performed to evaluate anxiety-like responses (Rubino et al., 2008) arms. An arm entry was counted when the animal moved both front paws into the arm.
Fear conditioning
Training and testing were conducted as described previously with some modifications (Bilkei-Gorzo et al., 2012; Na et al., 2012; Flores et al., 2014; Soria-Gómez et al., 2015) . Mice were individually placed in a shuttle chamber (LE918, Panlab, Barcelona) surrounded by a soundattenuating cabinet (Flores et al., 2014) . The chamber floor was formed by parallel stainless-steel bars connected to a scrambled shock generator. On the training day, mice were habituated to the chamber during 180 s before the exposure to an acute beeping 30 s sound (80 dB) repeated 3 times with a 10 s silenced interval. Each animal received an unconditioned stimulus (US) (0.7 mA footshock during 2s) paired with the end of each sound (conditioned stimulus, CS). After the third shock, the animal remained 30 s in the shuttle chamber. To test context-induced fear conditioning, mice were placed in the shuttle chamber 24 h after the training. Fear memory was assessed as the percentage of time that mice spent freezing during the first 3 min. Freezing response, a rodent's natural response to fear, was evaluated by direct observation and defined as complete lack of movement, except for respiration for more than 1 s. To evaluate cued fear conditioning (session 1), mice were re-exposed to the CS in a novel environment (a wide dark cylinder) 24 h after context acquisition. Mice were allowed to adapt for 3 min to the new environment which was followed by 30 s of the sound used in the training day. This sound was repeated 4 times with a 10 s interval. Freezing was scored during the time the sound was active. After the last sound trial, mice remained in the cylinder for 30 s.
Extinction training
Extinction training was initiated 24 h after the cue-dependent fear conditioning test. Mice were placed in the fear conditioning cylinder with a novel environment as described above. Mice were given once daily extinction training sessions for 5 days (sessions 2-6). The percentage of freezing time was calculated by following the same experimental procedure as in the session 1. The habituation time was reduced to 1 min as mice were previously adapted to the new context. Data from fear extinction in adult male mice exposed to THC and stress during the adolescent period were expressed as percentage of freezing behaviour and as area under the curve (AUC). AUC was calculated by using a standard trapezoid method,
where Bn were the percentage of freezing behaviour for each mouse and h was the time (days) passed between the consecutive measurements (Gibaldi and Perrier, 1975 ).
Immunoblot analysis
Amygdala tissue was extracted 25 days after the last THC or vehicle administration (PND74). Tissue was immediately frozen and store at −80°C. Amygdala was homogenized in 30 vol lysis buffer containing protease and phosphatase inhibitors. Samples were then centrifugated to eliminate any solid residue. Equal amounts of protein samples (20μg/ well) were separated in 10% polyacrylamide gels before electrophoretic transfer onto to nitrocellulose membranes (Bio-Rad). Membranes were blocked during 1 h in 5% bovine serum albumin (BSA)-T-TBS prior incubation for 2 h with the primary antibodies: CB1 cannabinoid receptor (CB1R) (rabbit polyclonal, 1:500) and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH, mouse monoclonal, 1:15000) form Frontier Institute (Cb1-Rb-Af380-1) and Santa Cruz Biotechnology (sc-32233), respectively. Then, membranes were rinsed 3 times and incubated for 1 h with their corresponding secondary antibodies coupled to horseradish peroxidase: rabbit (1:10000) and mouse (1:10000) from Cell Signaling. Immunochemiluminescence was produced by incubation of the membranes with West-femto ECL substrate (Thermo Fisher Scientific). Images of immunoreactive bands were acquire on a ChemiDoc XRS System (Bio-Rad) and quantified by The Quantity One software v4.6.3 (Bio-Rad). The values obtained for CB1R were normalized to the detection of GAPDH in the same sample and expressed as a percentage of the control group (Vehicle-Non stress) (Fig. S3 ).
Plasma corticosterone quantification
Blood samples were collected at different time points: immediately after restraint (PND 49), at PND 67 (basal), and 30 min after training (PND 72), cued-fear conditioning (session 1) (PND 74) and cued-fear extinction (session 5) (PND 78) (Fig. 3A) . Blood samples were obtained from the tail in tubes containing ethylenediaminetetraacetic acid. Double-antibody radioimmunoassay (RIA) was used to determine plasma corticosterone levels. RIA used 125I-corticosterone-carboximethyloxime-tyrosine-methyl ester (ICN-Biolink 2000, Spain), synthetic corticosterone (Sigma, Spain) as the standard, and an antibody raised in rabbits against corticosteronecarboxi-methyloxime-BSA kindly provided by Dr G. Makara (Institute of Experimental Medicine, Budapest, Hungary). Plasma corticosteroid-binding globulin was inactivated by low pH. All samples to be statistically compared were quantified in the same assay to avoid inter-assay variability.
Immunofluorescence
Two h after the last cued fear extinction session or just before behavioural testing, mice were deeply anesthetized by ip injection (0.2 ml/10g body weight) of a mixture of ketamine (100 mg/kg) and xylazine (20 mg/kg) prior to rapid intracardiac perfusion. Mice were intracardically perfused with 4% paraformaldehyde (PFA) solution. Brains were removed from skull and post-fixed in PFA for 24 h at 4°C. Then, brains were transferred to a solution of 30% sucrose in PB 0.1M and kept at 4°C. Coronal sections of 30 μm containing the prelimbic (PL) and infralimbic (IL) prefrontal cortex (from bregma 1.98 mm-1.54 mm) and the basolateral amygdala (BLA) (from bregma −1.22 mm to −1.82 mm) were obtained using a microtome. Brain slices were stored in a solution of 5% sucrose PB 0.1M. Free floating slices were rinsed in PB 0.1M and after blocked in a solution containing 3% donkey serum and 0.3% Triton X-100 in PB 0.1M (DS-T-PB) during 2 h at room temperature. Slices were incubated overnight with the primary antibody anti-c-Fos in DS-T-PB at 4°C (1:500, rabbit, Santa Cruz Biotechnology) (sc-7202). Next day, after three rinses with PB 0.1M, slices were incubated with the secondary antibody AlexaFluor-555 donkey anti-rabbit (1:500, Life Technologies) at room temperature for 2 h in DS-T-PB. Then, slices were rinsed three times and mounted with Mowiol onto glass slides coated with gelatin.
Immunofluorescence image analysis
The stained sections were analyzed at 10× objective using a Leica DMR microscope (Leica Microsystems, Wetzlar, Germany) equipped with a digital camera Leica DFC 300FX (Leica Microsystems). For PL and IL analysis, a 430 μm sided square region of interest (ROI) was delimited for quantification. The expression of cFos in the images was quantified using the ImageJ analysis software. The option "particle counting" under a fixed threshold configuration was used to detect cFos positive cells. For all areas, 4 images per mice were quantified. Data are expressed as density of cFos positive cells per mm 2 (6-9 mice per each experimental condition).
Ballistic labeling with the fluorescent dye DiI
Mice were deeply anesthetized after the last cued fear extinction session by ip injection (0.2 ml/10g body weight) of a mixture of ketamine (100 mg/kg) and xylazine (20 mg/kg) prior to rapid intracardiac perfusion. Mice were perfused with 10 ml of PBS 0.1M, pH 7.5 followed by 40 ml of 4% (PFA) in PB 0.1M. Brains were postfixed in 4% PFA for 10 min. Then, brains were kept in PBS 0.1M for 12 h. Brain coronal sections (100 μm) containing the amygdala (from bregma −1.22 mm to −1.82 mm) were obtained by using a vibratome (Leica VT 1000 S) and kept in PBS 0.1M until fluorescent labeling processing. Brain slices were labeled by ballistic delivery of fluorescent dye DiI (Molecular Probes) using a gene gun apparatus (Helios Gene Gun System, Bio-Rad) as described previously (Gan et al., 2009 ) and postfixed with PFA for 4 h at room temperature to further preserve structures and to allow the diffusion of the dye DiI. Sections were placed on microscope gelatinecoated slides and coverslipped with mounting medium (Mowiol). Images were acquired using a confocal microscope (Leica TCS Sp5 STED) with a glycerol immersion lens (63X/1.30). Individual pyramidal neurons from the BLA were chosen for spine analysis based on several criteria, as previously described (Saravia et al., 2017) . Briefly, (i) there was minimal or no overlap with other labeled cells to ensure that processes from different cells would not be confused, (ii) at least 3 primary dendrites needed to be visible for cells to be used for analysis and (iii) distal dendrites (from secondary dendrites to terminal dendrites) were examined. In addition, we chose only one apical or basal dendrite per neuron and quantified a minimum of 6 dendrites per animal. To calculate spine density, a minimum dendrite length of 20 μm long was required. All images of dendrites were taken at different z levels (0.13 μm depth intervals) to examine the morphology of dendritic spines. Reconstruction of dendrites and spine classification was performed using the IMARIS software (Bitplane). Protrusions from dendrites were classified into 5 types based on their morphology: class 1 or stubby protuberances were 0.5 μm in length, lacked a large spine head, and did not appear to have a neck; class 2, or mushroom-shaped spines were between 0.5 and 1.25 μm in length and were characterized by a short neck and large spine head; class 3, or thin spines ranged between 1.25 and 3.0 μm and had elongated spine necks with small heads; class 4, or filipodia were 1.0 and 2.5 μm in length and were characterized by a large neck without spine head; and class 5 or branched spine ranged between 1.25 and 3.0 μm and had elongated spine necks with 2 or more spine heads. Quantification of dendritic spine densities was performed in blind conditions.
Data analysis
Data were analyzed by using unpaired Student t-test, two-way ANOVA or two-way ANOVA with repeated measures followed by subsequent post hoc analysis (Fisher LSD) when required. The Pearson correlation coefficient was used to analyse the relationship between cFos expression and freezing values. A p value < 0.05 was used to determine statistical significance. The statistical analysis was performed using STATISTICA (StatSoft) software.
Results
Adolescent THC treatment does not modify fear extinction in adulthood
Adolescent male mice were treated with increasing doses of THC during 15 days (PND 35-39: 3 mg/kg, PND 40-44: 6 mg/kg, and PND 45-49: 12 mg/kg). Body weight was daily evaluated along THC treatment. When mice reached adulthood, the effects of adolescent THC administration on fear memory processing were analyzed (Fig. 1A) . Possible changes in locomotor activity and anxiety-like behaviour were also examined (Fig. 1A) . The weight gain of mice treated with THC was lower than those exposed to vehicle (Fig. 1B) , as previously reported (Rubino et al., 2008; Stopponi et al., 2014; Scherma et al., 2016 ). An anxiogenic-like effect induced by a high dose of THC could explain the changes in body weight. Indeed, one week after the finishing of the treatment, a higher level of anxiety-like behaviour in adolescent rodents exposed to THC compared to controls was found in the elevated plus maze (EPM) test in previous studies (Stopponi et al., 2014) . Nonspecific inhibition of ingestion, secondary to the sedative effects of THC could also be involved in this effect on body weight. Locomotor activity (p = 0.96, Student t-test) (Fig. 1C) and anxiety-like responses (p = 0.44, Student t-test) (Fig. 1D) (Fig. S2A ) of adult mice were not affected by the chronic treatment with THC. The administration of THC did not modify the acquisition of fear memory as shown by similar freezing behaviour in both contextual (p = 0.94, Student t-test) and cued (p = 0.78, Student t-test) fear conditioning tests ( Fig. 1E and F  (Session1) ). In addition, cued fear extinction was similar in adult animals exposed to THC or vehicle (Fig. 1F) . Thus, two-way ANOVA of repeated measures showed no interaction between THC treatment and day (F 5,130 = 1.22, p = 0.30) (Fig. 1F) .
In an additional experiment, fear memory processing was not modified either in female mice (Fig. S1 ), in spite of the different sensitivity observed in several behavioural responses after treatment with cannabinoid agonists between sexes . Our results indicate that THC administration during adolescence does not alter locomotion, anxiety and fear memory processing in adult male and female mice.
Concomitant THC and stress exposure during adolescence impairs fear extinction in adulthood
Cannabis consumption and environmental factors, such as stressful events, often coexist during adolescence and these factors could exacerbate the detrimental effects of cannabis use in adulthood. To test this hypothesis, we evaluated the consequences of simultaneous adolescent THC and stress exposure on locomotion, anxiety-like behaviour and fear memory processing in adult male mice. For this purpose, one stressor was applied at the end of each THC exposure period as shown in Fig. 2A . Two additional stress exposures were applied before behavioural evaluation ( Fig. 2A) . Adolescent mice receiving THC, independently of stress exposure, showed again a significant resistance to gain weight (Fig. 2B) . Locomotor activity during adulthood was not modified by THC treatment, stress exposure or by the interaction of both factors (Fig. 2C) . Mice that underwent stress, independently of THC exposure, showed an increase in anxiety-like behaviour. Thus, adolescent stressed mice spent significantly less time in open arms in the EPM (stress effect: F 1,60 = 4.17, p < 0.05) (Fig. 2D) , without significant interaction between THC and stress. This effect was not due to differences in the total number of entries (Fig. S2B) . The acquisition of fear memory was not altered in adult mice exposed to stress, THC or both factors simultaneously during adolescence. Thus, freezing levels were similar in both contextual (F 1,58 = 2.62, NS) and cued (F 1,59 = 2.69, NS) fear conditioning tests (Fig. 2E and F (Session 1)) . Notably, concomitant THC and stress exposure impaired cued fear extinction (Fig. 2F) . Two-way ANOVA with repeated measures revealed a significant interaction between THC and stress (F 1,59 = 9.38, p < 0.01), without other two-way or three-way interactions. Two-way ANOVA analyzed for each individual session revealed a significant interaction between stress and THC from session 4 to session 6 (F 1,59 = 10.26, p < 0.01 at session 4; F 1,59 = 5.45, p < 0.05 at session 5; F 1,59 = 15.56, p < 0.01 at session 6). Subsequent post hoc analysis showed higher freezing levels in mice simultaneously exposed to THC and stress in comparison with those treated with THC (p < 0.05 at session 5; p < 0.01 at session 4 and 6), exposed to stress (p < 0.01 at session 4, 5 and 6), and vehicle non-stress mice (p < 0.01 at session 4 and 6; p < 0.05 at session 5) (Fig. 2F) . In agreement, freezing levels expressed as AUC (Fig. 2G) were higher in mice exposed simultaneously to THC and stress in comparison with the other experimental conditions, as revealed by two-way ANOVA (interaction THC x stress: F 1,59 = 8.51, p < 0.01) and post hoc analysis (p < 0.01). We next evaluated whether the impairment in cued fear extinction could be related to an alteration of CB1R levels in the amygdala. CB1R in this brain region plays a crucial role in the modulation of fear processing (Gunduz-Cinar et al., 2013) . Western blot analysis showed no differences in total CB1R levels in the amygdala of adult mice exposed to THC and/or stress during the adolescent period (interaction THC x stress: F 1,19 = 1.99, p = 0.17) (Fig. S3) . This result suggests that, under our experimental conditions, impairment in fear extinction is not influenced by a reduced expression of CB1R in the amygdala of adult animals. However, changes in the efficacy or efficiency of the receptor binding can occur independently from the status of the receptor density, contributing to the observed phenotype.
To elucidate whether immature brain represents a period of development more susceptible to the effects of THC and stress, we compared the consequences of exposing the same type of stressors and THC treatment during adolescence and adulthood period (Fig. S4A) . For this purpose, changes in behaviour in adult male animals were evaluated exactly 20 days following the final day of THC administration ( Fig.  S4A) , as previously studied after exposure during the adolescent period. Notably, no differences in cued fear processing were observed between the different experimental groups exposed to THC and/or stress in adulthood period (Fig. S4B and C) , suggesting that adolescence is a sensitive window for the harmful consequences of concomitant THC and stress exposure.
3.3. Concomitant THC and stress exposure during adolescence increases corticosterone levels following cued fear conditioning session Stress during early-stages can impair fear extinction by modulation of glucocorticoid activity (Green et al., 2011) . Therefore, we next evaluated possible changes in plasma corticosterone levels due to THC and stress exposure during adolescence at different time points (Fig. 3A) . Corticosterone levels measured immediately after restraint stress exposure were significantly increased in stressed mice (stress effect: F 1,27 = 300.43, p < 0.01) (Fig. 3B) , without influence of THC treatment (Veh-non stress: 68.38 ± 8.8 ng/ml; Veh-stress: 333.57 ± 11.57 ng/ml; THC-non stress: 82.25 ± 19.44; THC-stress: 365.38 ± 19.12 ng/ml). Basal levels of corticosterone after previous THC and stress exposure (PND 67) were unaltered in the different experimental groups (Fig. S5) . Corticosterone levels measured 30 min after fear conditioning training were higher than in basal conditions, but remained similar in all experimental groups (Fig. 3C) . Interestingly, previous simultaneous exposure to THC and stress increased plasma corticosterone 30 min after cued fear conditioning testing, as shown by two-way ANOVA (interaction treatment x stress: F 1,27 = 5.76, p < 0.05) (Fig. 3D) , and post hoc analysis (p < 0.01), THC-stress (132.88 ± 8.06 ng/ml) versus THC-non stress mice (89.13 ± 5.33 ng/ ml) (Fig. 3D) . This imbalance of corticosterone activity was temporal since similar levels were again observed after the fifth cued extinction session (Fig. 3E) . These results suggest that glucocorticoid sensitization after cued fear conditioning may contribute to the extinction deficits revealed in mice exposed to THC and stress during the adolescent period.
3.4. Impaired fear extinction induced by concomitant THC and stress exposure is associated with reduced activity of the infralimbic prefrontal cortex and the basolateral amygdala To identify the brain areas responsible for the resistance to fear extinction induced by simultaneous THC and stress exposure, we analyzed the possible activation of brain regions closely involved in the extinction circuit by using cFos immunofluorescence. cFos expression in the PL, IL and BLA was evaluated 2 h after the last cued fear extinction session, as behavioural alteration remained present at this time point. cFos expression in the PL was not altered in the different experimental groups (F 1,20 = 1.05, NS) (Fig. S6) . Interestingly, IL activation was reduced by the previous concomitant exposure to THC and stress (p < 0.01), as shown by two-way ANOVA (interaction treatment x stress F 1,32 = 6.70, p < 0.05) (Fig. 4A and B) . Likewise, simultaneous THC and stress adolescent exposure reduced the activity of the BLA as revealed by two-way ANOVA (interaction treatment x stress F 1,28 = 4.51, p < 0.05), and post hoc analysis (p < 0.05) (Fig. 4C and D) . Values of cFos expression in the BLA for the different experimental groups were the following: Veh-non stress: 144.03 ± 12.21 cFos + cells/mm 2 ; Veh-stress: 149.97 ± 14.12 cFos + cells/mm 2 ; THC-non stress: 138.60 ± 7.98 cFos + cells/mm 2 ; THC-stress: 108.83 ± 9.75 cFos + cells/mm 2 ). These results show that the impaired fear extinction induced by adolescent THC and stress exposure is associated with reduced activity of the IL and the BLA, which are key regions involved in the extinction of aversive memories. Indeed, a significant negative correlation (p < 0.05) between fear memory (freezing values) and IL activity (density of cFos + cells) was observed (Fig. 4E) , whereas a clear tendency (p = 0.058) was revealed in the BLA (Fig. 4F) . In an additional experiment cFos expression was analyzed in the BLA and the IL in adult mice exposed to THC and stress during the adolescence just before and after the fear conditioning and extinction paradigm. These experiments were carried out in order to investigate whether the reduction in the activity of these brain areas was due to the THC-stress treatment or if these changes were influenced by the dynamic interplay among THC, stress and fear conditioning/extinction. Simultaneous THC and stress adolescent exposure reduced the activity of the BLA (interaction THC x stress: F 1,23 = 9.52, p < 0.05) (Fig. S7A ) and the IL (interaction THC x stress: F 1,22 = 5.66, p < 0.05) (Fig. S7B) after cued fear extinction, as previously reported. Interestingly, cFos expression was higher in adult animals exposed to THC and stress during the adolescence that did not undergo fear conditioning/extinction in both the BLA (p < 0.05) (Fig. S7A ) and the IL (p < 0.01) (Fig.  S7B ) in comparison with mice that followed the behavioural paradigm. These results suggest that the reduced activity observed in the BLA and the IL depends on the dynamic effect of THC-stress exposure followed by fear conditioning and extinction behavioural testing.
3.5. Impaired fear extinction induced by concomitant THC and stress exposure is associated with structural plasticity alterations in the basolateral amygdala
Stress has been reported to alter structural plasticity in the amygdala (Leuner and Shors, 2013) , affect fear extinction (Maren and Holmes, 2016) , and THC exposure during adolescence can induce changes in dendritic spines in several brain regions (Rubino and Parolaro, 2016) . Given the crucial role played by the BLA in fear extinction, we investigated whether concomitant exposure to THC and stress could affect structural plasticity in this brain area. Mice were sacrificed after the last cued extinction session and brains were processed for ballistic delivery to label whole neurons with the dye DiI. Total dendritic spine density of BLA pyramidal neurons was not modified by THC, stress or by the combination of both factors (Fig. 5A ). Dendritic spines are dynamic and can be classified into different categories depending on their morphology (stubby, mushroom, thin, branched and filopodia). Density of mushroom (mature) spines was reduced in adolescent mice treated with THC (independently of stress exposure) (p < 0.01), as revealed by two-way ANOVA (treatment effect: F 1,23 = 9.35, p < 0.01) (Fig. 5B and C) . THC treatment increased the density of thin (immature) spines (treatment effect: F 1,23 = 7.43, p < 0.05) (Fig. 5B and C) . Notably, this effect was mainly due to the concomitant exposure to THC and stress as revealed by post hoc comparisons. Thus, THC-stress mice showed higher density of thin spines in comparison with THC-non stress (p < 0.05), vehicle-stress (p < 0.05), and vehicle-non stress (p < 0.01) mice ( Fig. 5B and C) . These data suggest that changes in the density of immature spines in the BLA might be involved in the impairment of fear extinction associated with the combination of THC and stress exposure during the adolescence.
Discussion
To the best of our knowledge, this is the first study demonstrating synergistic detrimental effects of simultaneous adolescent THC and stress exposure on the extinction of aversive memory in adulthood. Notably, impaired fear extinction was associated with a temporal imbalance of plasmatic corticosterone levels, decreased activity of key regions involved in fear regulation, such as the IL and the BLA, and changes in structural plasticity revealed by increased immature dendritic spines density in pyramidal neurons of the BLA.
The administration of THC during adolescence in male and female mice did not induce any modification in locomotor activity, anxiety-like responses, and fear regulation later in life. Controversial results have been previously reported after adolescent THC exposure since general anxiety by using EPM was not modified in adult rats (Rubino et al., 2008; Cadoni et al., 2015) , whereas an anxiogenic-like effect was revealed in adult CD1 mice (Murphy et al., 2017) . In agreement with our data, no lasting effects by adolescent THC exposure were previously observed in aversive memory as revealed by the lack of deficits in passive avoidance task (Rubino et al, 2009a (Rubino et al, , 2009b or cued and contextual fear conditioning (Ballinger et al., 2015) . However, a longlasting impairment of fear conditioning has been described after chronic administration of the synthetic cannabinoid WIN 55,212-2 during adolescence (Gleason et al., 2012; Tomas-Roig et al., 2017) , which has a higher intrinsic activity on cannabinoid receptors than THC (Kuster et al., 1993) . On the other hand, repeated adolescent CB1R antagonism induced greater contextual fear memory recall in adult Fig. 4 . Impaired fear extinction in adulthood induced by concomitant adolescent THC and stress exposure is associated with a reduced activity of infralimbic prefrontal cortex and basolateral amygdala. (A,C) Density of cFos-expressing cells in (A) IL and (C) BLA 2 h after the last cue extinction session of adult mice exposed to THC, stress, or concomitant THC/stress during adolescence (n = 8-9 mice per group). (B,D) Schematic representation of the anatomical location of (B) IL and (D) BLA adapted from Paxinos and Franklin's stereotaxic atlas (Paxinos and Franklin, 2001) , and representative images of both regions obtained by fluorescence microscopy after direct labelling with rabbit polyclonal antiserum to cFos. (E,F) Correlation between fear memory (freezing values) and (E) IL and (F) BLA activity (density of cFos + cells) after the last cue extinction session. Scale bar represents 100 μm. Data are expressed as mean ± SEM. ★p < 0.05; ★★p < 0.01 (comparison between THC/stress and THC/non stress mice). IL: infralimbic prefrontal cortex. BLA: basolateral amygdala. (Fisher LSD test).
female, but not male, rats in comparison with control animals (Simone et al., 2018b) . Fear extinction, which has not been previously evaluated, was not affected in either male or female mice by adolescent THC treatment under our experimental conditions.
Although the exact cause of most psychiatric illnesses is not well known, it is becoming clear that many of these conditions are caused by the combination of genetic and environmental factors or by the association between different environmental events (Caspi and Moffitt, 2006; Rubino and Parolaro, 2016) . Stress has a critical role in the development of many psychiatric conditions including trauma-related disorders (Maren and Holmes, 2016) . Fear extinction deficits have been reported following exposure to various types of stressors in either animal models (Maren and Holmes, 2016) or humans (Hartley et al., 2014) . Thus, adolescent rodents exposed to chronic stress usually show impaired extinction when tested as adults (Judo et al., 2010; Ishikawa et al., 2012; Toledo-Rodriguez et al., 2012; Skelly et al., 2015) , although different results have been reported depending on the sex and the modality, chronicity and precise timing of stress exposure during adolescence (Morrissey et al., 2011; McCormick et al., 2013; Schayek and Maroun, 2015; Deng et al., 2017) . We found that adolescent stress exposure enhanced anxiety-like behaviour, but did not modify fear conditioning in adult mice. In contrast, concomitant adolescent THC and stress exposure induced an impairment of fear extinction in adulthood without affecting the acquisition of fear memory or general anxiety. Notably, the effect of this THC/stress exposure was age-dependent as revealed by the lack of deficits in fear extinction when the same exposure was performed directly in adulthood. Impaired extinction was not observed by the individual exposition to each factor suggesting synergistic detrimental consequences of adolescent cannabis and stressful events. In this regard, chronic adolescent treatment with Fig. 5 . Impaired fear extinction in adulthood induced by concomitant adolescent THC and stress exposure is associated with structural plasticity alterations in the basolateral amygdala. (A) Overall dendritic spine density, (B) analysis of spine morphology and (C) representative DiOlistics staining of BLA pyramidal neurons after the last cue extinction session of adult mice exposed to THC, stress, or concomitant THC/stress during adolescence (n = 6-8 mice per group). Arrows indicate thin (inmature) spines. Scale bar represents 2 μm. Data are expressed as mean ± SEM. ★p < 0.05 (comparison between THC/stress and THC/non stress mice); ★★p < 0.01 (comparison between THC and vehicle groups). BLA: basolateral amygdala. (Fisher LSD test) .
THC induced a deficit in cued fear conditioning only in adult mice with a mutation in disrupted-in-schizophrenia 1 gene (Ballinger et al., 2015) , although the influence of this genetic and environmental interaction in fear extinction was not evaluated in this study. Animals simultaneously exposed to THC and stress during adolescence showed a temporal imbalance of plasmatic corticosterone levels in the adult period as revealed by the increase of this hormone following the cued fear conditioning session. Although the association between glucocorticoids and fear extinction is complex, this enhancement of the hypothalamic-pituitary-adrenal (HPA) axis activity could participate in the extinction deficits and changes in structural plasticity revealed in our study. Thus, a single exposure to immobilization stress in adult male mice activates the HPA axis by increasing corticosterone plasma levels (Andero et al., 2011) . A week after this stress exposure mice present impaired cued-fear extinction and enhanced levels of corticosterone after both fear acquisition and fear extinction (Sawamura et al., 2016) . Moreover, acute corticosterone administration in adult rats induced dendritic hypertrophy of BLA neurons and enhanced anxiety 12 days after the treatment (Mitra and Sapolsky, 2008; Kim et al., 2014) .
IL and BLA are key structures involved in the neurobiological substrate underlying fear extinction (Sierra-Mercado et al., 2011) . IL facilitates the activation of the subpopulation of BLA neurons directly involved in fear extinction (Herry et al., 2008) . Several studies evaluating immediately-early gene (IEG) expression conclude that impaired fear extinction is associated with reduced activity of the corticoamygdala circuit (Herry and Mons, 2004; Holmes and Singewald, 2013) , while increased IEG levels in those brain areas is related to a complete extinction of conditioned fear (Herry and Mons, 2004; Flores et al., 2014) . Notably, our data reveal a reduced cFos expression in the IL and the BLA in adult mice simultaneously exposed to THC and stress during the adolescent period suggesting the existence of a long-lasting dysregulation of the fear circuit. In contrast, PL activity was not modified consistent with a role for this brain area in fear expression, but not extinction (Sierra-Mercado et al., 2011) . Besides these modifications on brain region activity, we found structural plasticity changes in pyramidal neurons of the BLA in adulthood as a consequence of adolescent THC treatment, alone or in combination with stress. A decrease of mushroom (matures) dendritic spines was revealed in mice previously exposed to THC congruent with previous studies showing reduced spine density in the dentate gyrus of the hippocampus (Rubino et al., 2009b) and the prefrontal cortex (Rubino et al., 2015) of adult male and female rats, respectively. Interestingly, simultaneous adolescent THC and stress exposure induced an increase of thin (immatures) spines in pyramidal neurons of the BLA in adult mice. These dendritic morphology modifications in BLA neurons associated with the decreased activity of this nucleus could be responsible of the deficits in the extinction of aversive memories. In agreement, fear extinction deficits following acute stress have been related to dendritic retraction in pyramidal neurons of both BLA (Maroun et al., 2013) and IL (Moench et al., 2016) .
In summary, our data show lasting neurobiological changes associated with resistance to fear extinction due to concomitant adolescent THC and stress exposure. This study identifies a potential social group highly vulnerable to develop anxiety disorders characterized by pathological fear after cannabis consumption, which contains multitude bioactive compounds (ElSohly et al., 2017) . Although our study was performed using pure THC, significantly higher THC concentrations in cannabis derived extracts over the years have been reported (Cascini et al., 2012; ElSohly et al., 2016) , which could cause an increase of the total amount of THC consumed. This increase poses higher risk of cannabis use, particularly among adolescents (ElSohly et al., 2016) . Taking into account the high rate of cannabis intake during this period which usually entails stressful events, the combination of both factors may increase the risk to suffer anxiety disorders in the adult period. Indeed, the exposure to stressful events during adolescence that often occur in cannabis consumers may represent an important risk factor to suffer anxiety disorders in adulthood.
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